We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$82.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
1 quarter
Avg Time Held Equity only
4.4 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
1 quarter

Top Buys

Rank Stock Value
1
JNPR icon
Juniper Networks
JNPR
+$162M
2
AXNX icon
Axonics, Inc. Common Stock
AXNX
+$128M
3
ANSS icon
Ansys
ANSS
+$119M
4
X icon
US Steel
X
+$104M
5
CTLT icon
CATALENT, INC.
CTLT
+$93.3M

Top Sells

Rank Stock Value
1
SPLK icon
Splunk Inc
SPLK
+$561M
2
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$120M
3
IMGN icon
Immunogen Inc
IMGN
+$56.8M
4
CPRI icon
Capri Holdings
CPRI
+$44.2M
5
PXD icon
Pioneer Natural Resource Co.
PXD
+$34M

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Miscellaneous 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ICLR icon
351
Icon
ICLR
$12.7B
$327K 0.01%
+972
New +$287K
2024 Q1
0 quarters
SRPT icon
352
CALL
Sarepta Therapeutics
SRPT
$1.89B
$318K 0.01%
+35,000
New +$4.29M
2024 Q1
0 quarters
F icon
353
PUT
Ford
F
$48.5B
$313K 0.01%
570,900
-170,000
-23% -$2.06M
2022 Q2
7 quarters
PHAT icon
354
Phathom Pharmaceuticals
PHAT
$587M
$304K 0.01%
28,583
-14,626
-34% -$124K
2022 Q1
8 quarters
XRX icon
355
PUT
Xerox
XRX
$361M
$296K 0.01%
294,800
+46,000
+18% +$809K
2021 Q2
11 quarters
CRBP icon
356
Corbus Pharmaceuticals
CRBP
$104M
$294K 0.01%
+7,500
New +$185K
2024 Q1
0 quarters
EVLVW icon
357
DELISTED
Evolv Technologies Warrant
EVLVW
$294K 0.01%
478,241
– –
2021 Q3
10 quarters
VRDN icon
358
Viridian Therapeutics
VRDN
$2.11B
$288K 0.01%
16,457
-13,543
-45% -$263K
2022 Q1
8 quarters
XBI icon
359
CALL
State Street SPDR S&P Biotech ETF
XBI
$10B
$287K 0.01%
300,000
+125,000
+71% +$11.6M
2023 Q3
2 quarters
CYPH icon
360
Cypherpunk Technologies Inc
CYPH
$317M
$286K 0.01%
107,412
-36,177
-25% -$108K
2023 Q1
4 quarters
CRNX icon
361
DELISTED
Crinetics Pharmaceuticals
CRNX
$282K 0.01%
6,021
-4,017
-40% -$157K
2022 Q1
8 quarters
CCL icon
362
PUT
Carnival Corporation Ltd
CCL
$35.4B
$281K 0.01%
771,500
-250,000
-24% -$4.07M
2021 Q3
10 quarters
EPR icon
363
EPR Properties
EPR
$4.19B
$280K 0.01%
+6,600
New +$288K
2024 Q1
0 quarters
EDIT icon
364
Editas Medicine
EDIT
$445M
$278K 0.01%
37,403
-12,597
-25% -$105K
2023 Q1
4 quarters
GTY icon
365
Getty Realty Corp
GTY
$1.73B
$277K 0.01%
10,130
-70,963
-88% -$1.95M
2023 Q1
4 quarters
W icon
366
Wayfair
W
$14.5B
$272K 0.01%
4,000
-6,000
-60% -$339K
2023 Q2
3 quarters
CHTR icon
367
PUT
Charter Communications
CHTR
$11.8B
$260K 0.01%
+3,400
New +$1.09M
2024 Q1
0 quarters
NERV icon
368
Minerva Neurosciences
NERV
$152M
$257K 0.01%
99,644
+35,000
+54% +$215K
2023 Q3
2 quarters
CYH icon
369
CALL
Community Health Systems
CYH
$389M
$253K 0.01%
+525,000
New +$1.77M
2024 Q1
0 quarters
HTZ icon
370
PUT
Hertz
HTZ
$684M
$252K 0.01%
+181,900
New +$1.49M
2024 Q1
0 quarters
ADC icon
371
Agree Realty
ADC
$8.2B
$251K 0.01%
4,400
-79,992
-95% -$4.68M
2019 Q4
17 quarters
CRSP icon
372
PUT
CRISPR Therapeutics
CRSP
$5.16B
$242K 0.01%
+20,000
New +$1.43M
2024 Q1
0 quarters
PRAX icon
373
CALL
Praxis Precision Medicines
PRAX
$7.26B
$238K 0.01%
+27,100
New +$1.22M
2024 Q1
0 quarters
VNET icon
374
VNET Group
VNET
$1.57B
$233K 0.01%
+150,000
New +$277K
2024 Q1
0 quarters
XBI icon
375
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
$232K 0.01%
+90,000
New +$8.35M
2024 Q1
0 quarters
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.